Chapter/Section Purchase

Leave This Empty:

Global and United States Tafenoquine Market Insights, Forecast to 2027

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Tafenoquine Product Introduction
1.2 Market by Type
1.2.1 Global Tafenoquine Market Size Growth Rate by Type
1.2.2 Powder
1.2.3 Pills
1.3 Market by Application
1.3.1 Global Tafenoquine Market Size Growth Rate by Application
1.3.2 Radical Cure of P.vivax
1.3.3 P. falciparum Treatment
1.3.4 Prevention of Malaria Relapse
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Tafenoquine Market Size, Estimates and Forecasts
2.1.1 Global Tafenoquine Revenue 2016-2027
2.1.2 Global Tafenoquine Sales 2016-2027
2.2 Global Tafenoquine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Tafenoquine Historical Market Size by Region (2016-2021)
2.3.1 Global Tafenoquine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Tafenoquine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Tafenoquine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Tafenoquine Sales Forecast by Region (2022-2027)
2.4.2 Global Tafenoquine Revenue Forecast by Region (2022-2027)

3 Global Tafenoquine Competitor Landscape by Players
3.1 Global Top Tafenoquine Manufacturers by Sales
3.1.1 Global Tafenoquine Sales by Manufacturer (2016-2021)
3.1.2 Global Tafenoquine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Tafenoquine Manufacturers by Revenue
3.2.1 Key Tafenoquine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Tafenoquine Revenue by Manufacturers (2016-2021)
3.2.3 Global Tafenoquine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Tafenoquine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Tafenoquine Revenue in 2020
3.2.6 Global Tafenoquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Tafenoquine Price by Manufacturers
3.4 Global Tafenoquine Manufacturing Base Distribution, Product Types
3.4.1 Tafenoquine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tafenoquine Product Type
3.4.3 Date of International Manufacturers Enter into Tafenoquine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Tafenoquine Market Size by Type (2016-2021)
4.1.1 Global Tafenoquine Sales by Type (2016-2021)
4.1.2 Global Tafenoquine Revenue by Type (2016-2021)
4.1.3 Tafenoquine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Tafenoquine Market Size Forecast by Type (2022-2027)
4.2.1 Global Tafenoquine Sales Forecast by Type (2022-2027)
4.2.2 Global Tafenoquine Revenue Forecast by Type (2022-2027)
4.2.3 Tafenoquine Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Tafenoquine Market Size by Application (2016-2021)
5.1.1 Global Tafenoquine Sales by Application (2016-2021)
5.1.2 Global Tafenoquine Revenue by Application (2016-2021)
5.1.3 Tafenoquine Price by Application (2016-2021)
5.2 Tafenoquine Market Size Forecast by Application (2022-2027)
5.2.1 Global Tafenoquine Sales Forecast by Application (2022-2027)
5.2.2 Global Tafenoquine Revenue Forecast by Application (2022-2027)
5.2.3 Global Tafenoquine Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Tafenoquine Market Size YoY Growth 2016-2027
6.1.1 United States Tafenoquine Sales YoY Growth 2016-2027
6.1.2 United States Tafenoquine Revenue YoY Growth 2016-2027
6.1.3 United States Tafenoquine Market Share in Global Market 2016-2027
6.2 United States Tafenoquine Market Size by Players (International and Local Players)
6.2.1 United States Top Tafenoquine Players by Sales (2016-2021)
6.2.2 United States Top Tafenoquine Players by Revenue (2016-2021)
6.3 United States Tafenoquine Historic Market Review by Type (2016-2021)
6.3.1 United States Tafenoquine Sales Market Share by Type (2016-2021)
6.3.2 United States Tafenoquine Revenue Market Share by Type (2016-2021)
6.3.3 United States Tafenoquine Price by Type (2016-2021)
6.4 United States Tafenoquine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Tafenoquine Sales Forecast by Type (2022-2027)
6.4.2 United States Tafenoquine Revenue Forecast by Type (2022-2027)
6.4.3 United States Tafenoquine Price Forecast by Type (2022-2027)
6.5 United States Tafenoquine Historic Market Review by Application (2016-2021)
6.5.1 United States Tafenoquine Sales Market Share by Application (2016-2021)
6.5.2 United States Tafenoquine Revenue Market Share by Application (2016-2021)
6.5.3 United States Tafenoquine Price by Application (2016-2021)
6.6 United States Tafenoquine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Tafenoquine Sales Forecast by Application (2022-2027)
6.6.2 United States Tafenoquine Revenue Forecast by Application (2022-2027)
6.6.3 United States Tafenoquine Price Forecast by Application (2022-2027)

7 North America
7.1 North America Tafenoquine Market Size YoY Growth 2016-2027
7.2 North America Tafenoquine Market Facts & Figures by Country
7.2.1 North America Tafenoquine Sales by Country (2016-2021)
7.2.2 North America Tafenoquine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Tafenoquine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Tafenoquine Market Facts & Figures by Region
8.2.1 Asia Pacific Tafenoquine Sales by Region (2016-2021)
8.2.2 Asia Pacific Tafenoquine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Tafenoquine Market Size YoY Growth 2016-2027
9.2 Europe Tafenoquine Market Facts & Figures by Country
9.2.1 Europe Tafenoquine Sales by Country (2016-2021)
9.2.2 Europe Tafenoquine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Tafenoquine Market Size YoY Growth 2016-2027
10.2 Latin America Tafenoquine Market Facts & Figures by Country
10.2.1 Latin America Tafenoquine Sales by Country (2016-2021)
10.2.2 Latin America Tafenoquine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Tafenoquine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Tafenoquine Market Facts & Figures by Country
11.2.1 Middle East and Africa Tafenoquine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Tafenoquine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 GlaxoSmithKline Pharmaceuticals (GSK)
12.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
12.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
12.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Products Offered
12.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Development
12.2 J & K Scientific LTD
12.2.1 J & K Scientific LTD Corporation Information
12.2.2 J & K Scientific LTD Description and Business Overview
12.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 J & K Scientific LTD Tafenoquine Products Offered
12.2.5 J & K Scientific LTD Recent Development
12.3 BOC Sciences
12.3.1 BOC Sciences Corporation Information
12.3.2 BOC Sciences Description and Business Overview
12.3.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 BOC Sciences Tafenoquine Products Offered
12.3.5 BOC Sciences Recent Development
12.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
12.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Corporation Information
12.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
12.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Products Offered
12.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Development
12.5 Pharmacodia (Beijing) Co.,Ltd
12.5.1 Pharmacodia (Beijing) Co.,Ltd Corporation Information
12.5.2 Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
12.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Products Offered
12.5.5 Pharmacodia (Beijing) Co.,Ltd Recent Development
12.6 Amadis Chemical Company Limited
12.6.1 Amadis Chemical Company Limited Corporation Information
12.6.2 Amadis Chemical Company Limited Description and Business Overview
12.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Amadis Chemical Company Limited Tafenoquine Products Offered
12.6.5 Amadis Chemical Company Limited Recent Development
12.7 Merck
12.7.1 Merck Corporation Information
12.7.2 Merck Description and Business Overview
12.7.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Tafenoquine Products Offered
12.7.5 Merck Recent Development
12.11 GlaxoSmithKline Pharmaceuticals (GSK)
12.11.1 GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
12.11.2 GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
12.11.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Products Offered
12.11.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Tafenoquine Industry Trends
13.2 Tafenoquine Market Drivers
13.3 Tafenoquine Market Challenges
13.4 Tafenoquine Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tafenoquine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer